Trauma Therapy for Psychosis: Eye Movement Desensitisation and Reprocessing... | Recruiting
Trauma Therapy for Psychosis: Eye M... | Recruiting
Trauma Therapy for Psychosis: Eye Movement Desensitisation and Reprocessing (EMDR) for people with a psychotic illness
TTP

Location not identified by Google services

Location data is sourced from multiple external providers and UKCTG is not responsible for and cannot guarantee the accuracy of data.

Medical Conditions
  • Mental Health Difficuties
Primary Contact Details
Recruitment Status
Recruiting
Trial source and source ID number
ISRCTN43816889
This information is designed to help you decide whether this trial is of interest. In some cases it is provided as a link to more detailed patient information or it may still be awaited from the organisation running the trial. Please look again shortly if the information you need is not here or, if named, contact the researcher named above.
Summary
Background and study aims
Psychosis is a mental illness where those affected hear things that others may not be able to hear, and believe things that others find hard to believe. The suggested therapy is called Eye Movement Desensitisation and Reprocessing (EMDR) and is known to be safe and work well in treating disorders clearly linked to trauma such as Post-Traumatic Stress Disorder (PTSD). Psychosis is understood to be linked with trauma in a similar way to PTSD but this therapy has not been tested for how well it works in this illness. We hope to offer people with psychosis a new brief therapy treatment to reduce the impact of previous difficult or traumatic experiences.

Who can participate?
This study is open to patients who are known to suffer from psychosis and normally have support from the psychiatric services locally.

What does the study involve?
12 patients will be randomly allocated to not receive treatment but continue their normal care with the psychiatric services (treatment as usual). They will be offered the treatment at the end of the study. 24 patients will be randomly allocated to have the EMDR treatment. Everybody will have an interview with a researcher before and after the treatment period, as well 6 months after treatment. At these interviews patients will be assessed on measurement scales that test for the impact of previous traumatic events, the symptoms of psychosis and PTSD, and a measurement of their quality of life.

What are the possible benefits and risks of participating?
We hope to see that patients who receive this treatment have improvements in their symptoms of mental health problems as well as their quality of life. The potential risks of participating include the general risks of participating in a one-to-one therapy. These include increased distress and worsening of symptoms due to the process as well as not getting on with the therapist. These risks will be modified by providing patients with resources and skills to prepare for the treatment including use of relaxation exercises. There is a risk that the patient finds the process difficult and distressing but this risk will be modified by ensuring there is a thorough consent process, recruitment involves the awareness that the therapy is about treating previous traumatic experiences / memories, and the ensuring that patients are briefed about the EMDR therapeutic process before commencing.

Where is the study run from?
The study will be run from Cornwall Foundation NHS Trust (UK) sites. The trust is based at Shaw House, Porthpean Road, St Austell, Cornwall. Bases will include local Community Mental Health Team bases including Trevillis House, Liskeard; Elfordleigh, Launceston; East Resource Centre, Bude; Alexandra House, St Austell; Banham House, Bodmin; Newquay Resource Centre (Roswyth), Newquay; Pydar Street, Truro; Trengweath, Redruth; and Bolitho House, Penzance.

When is the study starting and how long is it expected to run for?
January 2015 to January 2017.

Who is funding the study?
Cornwall Partnership NHS Foundation Trust (UK)

Who is the main contact?
Dr Simon Marlow
simonmarlow@nhs.net
Research Details
  • We hypothesise that a providing EMDR therapy to patients with psychosis will lead to an improvement in the negative impact of a traumatic event, and subsequent improvements in the symptoms of psychosis, quality of life, and symptoms of post-traumatic stress disorder (PTSD).
Phase
Not Applicable
Study Design
Exploratory randomised control study of the treatment effectiveness of EMDR therapy in people with psychosis.
Study Type
Interventional
Intervention

Patients are randomised to two groups:
1. Eye Movement Desensitisation and Reprocessing Therapy: A course of 8 x 90 minute sessions.
2. The control group will have Treatment As Usual.

Intervention Type
Other
Primary Outcome Measures
    Impact of Events Scale (IES) measured at baseline, then after 10 weeks (to allow for the up to 8 week therapy course to complete) and then after 6 months from baseline.
Secondary Outcome Measures
    1. Positive and Negative Symptoms of Schizophrenia Scale (PANSS)
    2. Subjective Quality of Life (MANSA)
    3. PTSD Checklist (PCL)

    The measures will be done at baseline, then after 10 weeks (to allow for the up to 8 week therapy course to complete) and then after 6 months from baseline.
Publication(s)
Sorry, this information is not available
Result Reports
Sorry, this information is not available
This information is designed to help you decide whether this trial is of interest. In some cases it is provided as a link to more detailed patient information or it may still be awaited from the organisation running the trial. Please look again shortly if the information you need is not here or, if named, contact the researcher named above.
Gender
Both
Age Range
Adult
Who Can Participate
Patient
Number of Participants
36
Participant Inclusion Criteria
    Patients with a psychotic illness without comorbid PTSD currently receiving care from secondary care psychiatric services between the ages of 18-65.
Participant Exclusion Criteria
    Having a severe learning difficulty, being unable to speak English or travel to the appointments. Having a serious concern about risk or being placed in a locked psychiatric unit.
This information is designed to help you decide whether this trial is of interest. In some cases it is provided as a link to more detailed patient information or it may still be awaited from the organisation running the trial. Please look again shortly if the information you need is not here or, if named, contact the researcher named above.
Trial Location(s)
Redruth
TR15 2SP
Trial Contact(s)
Primary Trial Contact
Dr Simon Marlow
-
Other Trial Contacts
Sorry, this information is not available
Countries Recruiting
United Kingdom
This information is designed to help you decide whether this trial is of interest. In some cases it is provided as a link to more detailed patient information or it may still be awaited from the organisation running the trial. Please look again shortly if the information you need is not here or, if named, contact the researcher named above.
Scientific Title
The use of Eye Movement Desensitisation and Reprocessing (EMDR) for the treatment of psychosis
EudraCT Number
Sorry, this information is not available
Funder(s)
  • Cornwall Partnership NHS Foundation Trust (UK) - Research and Development Team
Other Study ID Numbers
v1.2
Sponsor(s)
Cornwall Foundation NHS Trust (UK)
Key Dates

Recruitment Start Date

01 Jan 2015

Recruitment End Date

01 Jan 2019

Trial Start Date

01 Jan 2015

Trial End Date

01 Jun 2019

Date added to source

24 Oct 2014

Date updated in source

31 Jan 2018